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Highlights 
 RYR1 mutations may be associated with arthrogryposis multiplex congenita. 
 Compound heterozygous malignant hyperthermia mutations cause myopathic 
phenotype. 
 Bleeding tendency should be anticipated with RYR1 genotypes. 
 
Abstract 
RYR1 mutations, the most common cause of non-dystrophic neuromuscular 
disorders, are associated with the malignant hyperthermia susceptibility (MHS) trait 
as well as congenital myopathies with widely variable clinical and histopathological 
manifestations. Recently, bleeding anomalies have been reported in association with 
certain RYR1 mutations. Here we report a preterm infant born at 32 weeks gestation 
with arthrogryposis multiplex congenita (AMC) due to compound heterozygous, 
previously MHS-associated RYR1 mutations, with additional signs of prenatal 
hemorrhage. The patient presented at birth with multiple joint contractures, scoliosis, 
severe thoracic rigidity and respiratory failure. He continued to depend on mechanical 
ventilation and tube feeding. Muscle histopathology showed a marked myopathic 
pattern with eccentric cores. Interestingly, the patient had additional unusual prenatal 
intraventricular hemorrhage, resulting in post-hemorrhagic hydrocephalus as well as 
epidural hemorrhage affecting the spinal cord. This report adds to the phenotypic 
variability associated with RYR1 mutations, and highlights possible bleeding 
complications in affected individuals. 
 
Keywords 
ryanodine receptor; RYR1; myopathy; arthrogryposis; CNS bleeding; malignant 
hyperthermia susceptibility trait  
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Introduction 
Arthrogyposis multiplex congenita (AMC) is due to a wide range of neurological and 
neuromuscular causes, the latter comprising a wide spectrum of genetically 
heterogenous congenital myopathies [1]. In addition to skeletal deformities such as 
multiple contractures, scoliosis and thoracic deformities, severely affected newborns 
may present with additional respiratory insufficiency, facial weakness, swallowing 
problems, and severe muscular hypotonia (as well as hypertonic muscle tone in 
extremely rare cases) [2-4]. The risk for intrauterine death as a consequence of 
severe fetal akinesia is well documented [5]. Muscle biopsy and confirmatory genetic 
testing are diagnostically most relevant, although non-specific myopathic changes 
may delay the correct diagnosis in newborns and young infants [1, 6]. Mutations in 
the skeletal muscle ryanodine receptor (RYR1) gene, encoding the principal 
sarcoplasmic reticulum (SR) Ca2+ release channel with a crucial role in excitation-
contraction coupling (ECC), are increasingly recognized as a common cause of 
various congenital myopathies [2, 7-8]: Whereas dominant mutations affecting 
mutational hotspots within the RYR1 gene are mainly associated with the malignant 
hyperthermia susceptibility trait (MHS), a pharmacogenetic predisposition to severe 
adverse reactions in response to halogenated anaesthetics and muscle relaxants (for 
review [9]), and the congenital myopathy Central Core Disease (CCD) [10], recessive 
mutations distributed throughout the RYR1 coding sequence give rise to a wide 
clinical-pathologic spectrum including Multi-minicore Disease (MmD) [11], 
Centronuclear Myopathy (CNM) [12], and Congenital Fiber Type Disproportion 
(CFTD) [13].  
Most patients with RYR1-associated myopathies present in infancy or early childhood 
with mild or moderate muscular hypotonia and motor developmental delay. In 
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addition, adult myopathic presentations [14-15] such as late-onset axial myopathy 
[16-17], or induced manifestations such as exertional myalgia/rhabdomyolysis (ERM) 
[18] are increasingly recognized, in particular in association with MHS-predisposing 
RYR1 mutations. At the other end of the spectrum, severe neonatal manifestations 
associated with both (often de novo) dominant and recessive RYR1 mutations have 
been reported [3-4]. In these patients decreased fetal movements, arthrogryposis 
multiplex congenita (AMC), polyhydramnios, scoliosis and respiratory distress are 
typically observed [1, 3-4, 19]. Recently, several cases with a lethal neonatal course 
have been documented [20], some of those within the spectrum of the “lethal multiple 
pterygium syndrome” [5]. Intrafamilial phenotypic variability has been reported in 
several families affected by such severe presentations [4, 20]. 
Lately, bleeding abnormalities have been described in patients with RYR1 mutations, 
in particular mutations also associated with the MHS trait and/or ERM [21]. This 
clinically relevant observation was confirmed and its molecular basis elucidated in an 
animal model of RYR1-associated malignant hyperthermia, the Y522S mouse [21]. 
Here we report complications of unexpectedly severe CNS bleeding in an infant with 
RYR1-associated AMC and a complex myopathic pattern comprising dystrophic 
features and eccentric cores on muscle biopsy. 
Case report 
This male infant was born to healthy non-consanguineous parents. The mother had 
previously lost a fetus in the 8th week of pregnancy. Pregnancy was complicated by 
polyhydramnios. Prenatal ultrasound suggested pulmonary hypoplasia. At 32 weeks 
gestation Caesarean section was performed due to premature rupture of 
membranes. Apgar score at 1 minute was 5 and ventilation was immediately 
instituted due to insufficient respiratory effort. Umbilical artery pH value was normal at 
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pH 7.39. Growth parameters were reduced for gestational age (birth weight 1240g-
3th percentile, length 33cm- accurate measurements hindered by extensive limb 
contractures) with head circumference within normal range (31.5 cm-90th percentile). 
The patient presented with arthrogryposis multiplex and extreme muscular 
hypertonia. Deep tendon reflexes were absent. Serum creatine kinase was within the 
normal range (230 IU/l and below on repeated controls). Thoracic rigidity and 
scoliosis confounded respiratory impairment and impeded successful mechanical 
ventilation. Additional dysmorphic features including camptodactyly, high forehead, 
narrow palpebral fissure, deep set eyes, long philtrum, small mouth with high palate 
and discrete retrognathia were noted (Fig.1). 
Using high frequency oscillation ventilation (HFO) respiratory parameters could be 
temporarily stabilized, but change to conventional modes of ventilation was not 
tolerated until the 14th day of life. CT scan of the lungs did not reveal any specific 
pulmonary abnormality. Subsequently, Neurally Adjusted Ventilatory Assist (NAVA) 
ventilation was successfully introduced and tolerated. At the age of 7 months 
tracheotomy had to be performed to enable ambulatory assisted ventilation and 
home care.  
Cranial MRI at the age of 8 weeks showed sequelae of a 2° hemorrhage arising from 
the left caudothalamic groove as well as a spinal epidural space-occupying lesion 
from cervical spine 5 to thoracic spine 9, suggesting an organized prenatal 
hemorrhage (Fig.2). Progressively abnormal increase in head circumference led to 
the diagnosis of post-hemorrhagic hydrocephalus internus, presumably caused by 
prenatal intracranial hemorrhage and confirmed on cranial ultrasound. Ventriculo-
peritoneal shunting was performed at the age of 4 months.  
Chromosomal analysis and molecular genetic analysis of SMN1, IGHMBP2, MTM1 
and DMPK genes excluded the clinically most relevant differential diagnoses. 
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Histopathological analysis of a diagnostic muscle biopsy taken at the age of 4 months 
from the vastus lateralis muscle showed complex myopathological features 
comprising increased endo- and perimysial connective and fatty tissue, rounding of 
muscle fibers with pathological fiber size variation, internalization of myonuclei as 
well as few degenerating fibers. Further, histochemical stains identified: 1) multiple 
fibers with eccentric cores, 2) fibers with focal accumulation of glycogen, 3) fibers 
with focal increase of acidic phosphatase reaction, and 4) multiple fibers with 
attenuated COX and SDH-enzyme reactivity (Fig.3). Biochemically, deficiency of 
mitochondrial respiratory chain complex I was found. However, as clinical signs and 
clinical course differed from complex-I-associated infantile myopathies, molecular 
genetic diagnostics were extended.  
Exome sequencing revealed compound heterozygous mutations in the ryanodine 
receptor (RYR1) gene (c.6488G>A, p.(Arg2163His); c.14918C>T, p.(Pro4973Leu)). 
No other variants were detected in genes related to arthrogryposis or increased 
bleeding risks. Genetic analysis of the parents confirmed recessive inheritance, 
showing heterozygosity for the (p.(Pro4973Leu)) mutation in the father and for the 
(p.(Arg2163His)) mutation in the mother.   
Genetic counseling of the young family was performed and additional genetic testing 
was arranged for other family members, especially with regards to the possibly 
increased malignant hyperthermia susceptibility (MHS) risk. On specific questioning, 
the parents reported cosegregation of the familial RYR1 mutations with variable 
degree of ptosis on both sides of the family, and increased sweating on the maternal 
side. 
The patient continued to make developmental progress but remained severely 
delayed, with part range antigravity movements only in the limbs. He required 
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percutaneous endoscopic gastrostomy (PEG) feeding and mechanical home 
ventilation. 
Discussion 
RYR1 mutations are associated with the malignant hyperthermia susceptibility (MHS) 
trait as well as a wide range of myopathies with variable clinico-pathological features. 
Severe forms of fetal akinesia, occasionally associated with neonatal lethality, 
represent the most severe end of the RYR1-associated spectrum and, so far, have 
only been reported in a limited number of patients [1, 3-4].  
Here we report a patient with a severe RYR1-associated early-onset myopathy, 
comprising features of arthrogryposis multiplex congenita (AMC), profound 
respiratory impairment and additional evidence of CNS bleeding of prenatal origin. In 
terms of overall severity, our patient falls within the severe end of recessive RYR1-
related myopathies, where patients may be premature and present with breathing 
and feeding difficulties requiring ventilation support and gastrostomy feeds [1, 3, 22].  
The patient was found to be compound heterozygous for a maternally inherited RYR1 
c.6488G>A mutation, previously associated with MHS and cores on muscle biopsy 
[23], and a paternally inherited RYR1 c.14918C>T mutation also previously 
implicated in the MHS trait [24-25] supporting the notion that some RYR1 mutations 
behave as dominants with regards to the MHS trait but as recessives with regards to 
congenital myopathy phenotypes [7, 26]. Exome sequencing did not show any other 
mutations in our patient. Recessive RYR1-related myopathies are predominantly due 
to compound heterozygosity for RYR1 loss-of-function mutations and missense 
mutations, the latter also occasionally associated with the MHS trait [7-8, 15]. 
Compound heterozygosity or homozygosity for MHS-associated RYR1 mutations is 
less common, but has been reported in some patients with widely variable clinical-
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pathologic features [26-27] sometimes distinct from other forms of recessive RYR1-
related myopathies. Another distinct phenotype associated with MHS mutations is the 
King-Denborough syndrome (KDS) [28], a dysmorphic myopathic syndrome 
characterized by ptosis, short stature, scoliosis and a predisposition to often sporadic 
MHS episodes.        
Interestingly, our patient had additional features of two-stage CNS bleeding events 
that for several reasons are more likely to be due to his genetic background rather 
than his gestation: Firstly, prenatal intraventricular hemorrhage (IVH) is common in 
very preterm infants but incidence decreases with advancing gestational age and 
becomes increasingly rare after 32 weeks gestation [29]. Secondly, epidural 
hematoma affecting the brain is uncommon after atraumatic birth [30] and 
exceedingly rare in the spinal cord. Thirdly, Lopez et al. recently reported evidence 
for an increased bleeding tendency in RYR1- mutated patients [21] in whom other 
coagulation defects had been excluded, supporting the hypothesis of a similar 
genetic predisposition also in our patient. Interestingly, all of the patients reported by 
Lopez et al. were either heterozygous or compound heterozygous for RYR1 
mutations implicated in the MHS trait, corresponding to  the genotype also identified 
in our patient and in keeping with previous case reports of increased bleeding in 
patients with MHS [31-33]. Lopez et al. also demonstrated prolonged bleeding in the 
mouse model heterozygous for the RYR1 Y522S MHS mutation, and confirmed 
reduced vascular smooth muscle cell contractility as the pathophysiological cause for 
this observation [21]. Interestingly, mice homozygous for the RYR1 Y522S mutation 
have signs of an antenatal bleeding disorder presenting with marked subcutaneous 
bleeding and edema at birth. Moreover, a role of the RYR1 receptor in CNS 
vasoregulation is also supported indirectly by the recognized beneficial role of the 
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specific RYR1 antagonist dantrolene in the management of subarachnoid 
hemorrhage and other traumatic CNS events with a vascular component [34-35].    
We conclude that this report adds to the phenotypic variability of RYR1 mutations 
and may draw the attention of clinicians and researchers to the possibility of 
hemorrhagic complications associated with RYR1 mutations.  
  
Page 9 of 22
10 
 
Funding 
This research did not receive any specific grant from funding agencies in the public, 
commercial, or not-for-profit sectors. 
 
 
Acknowledgement 
We would like to express our appreciation to the family of the patient for their 
courageous cooperation. We give thanks to Uwe Ahting, MD, Institute of Human 
Genetics, Munich, Germany, for performing exome sequencing.  
  
Page 10 of 22
11 
 
References 
[1] Todd EJ, Yau KS, Ong R, et al. Next generation sequencing in a large cohort 
of patients presenting with neuromuscular disease before or at birth. Orphanet 
J Rare Dis  2015;10:148. 
[2] Maggi L, Scoto M, Cirak S, et al. Congenital myopathies--clinical features and 
frequency of individual subtypes diagnosed over a 5-year period in the United 
Kingdom. Neuromuscul Disord  2013;23:195-205. 
[3] Bharucha-Goebel DX, Santi M, Medne L, et al. Severe congenital RYR1-
associated myopathy: the expanding clinicopathologic and genetic spectrum. 
Neurology  2013;80:1584-9. 
[4] Romero NB, Monnier N, Viollet L, et al. Dominant and recessive central core 
disease associated with RYR1 mutations and fetal akinesia. Brain  
2003;126:2341-9. 
[5] Kariminejad A, Ghaderi-Sohi S, Hossein-Nejad Nedai H, Varasteh V, Moslemi 
AR, Tajsharghi H. Lethal multiple pterygium syndrome, the extreme end of the 
RYR1 spectrum. BMC Musculoskelet Disord  2016;17:109. 
[6] Ravenscroft G, Davis MR, Lamont P, Forrest A, Laing NG. New era in 
genetics of early-onset muscle disease: Breakthroughs and challenges. Semin 
Cell Dev Biol  2016. 
[7] Klein A, Lillis S, Munteanu I, et al. Clinical and genetic findings in a large 
cohort of patients with ryanodine receptor 1 gene-associated myopathies. 
Hum Mutat  2012;33:981-8. 
[8] Amburgey K, Bailey A, Hwang JH, et al. Genotype-phenotype correlations in 
recessive RYR1-related myopathies. Orphanet journal of rare diseases  
2013;8:117. 
Page 11 of 22
12 
 
[9] Rosenberg H, Davis M, James D, Pollock N, Stowell K. Malignant 
hyperthermia. Orphanet journal of rare diseases  2007;2:21. 
[10] Zhang Y, Chen HS, Khanna VK, et al. A mutation in the human ryanodine 
receptor gene associated with central core disease. Nat Genet  1993;5:46-50. 
[11] Jungbluth H, Zhou H, Hartley L, et al. Minicore myopathy with ophthalmoplegia 
caused by mutations in the ryanodine receptor type 1 gene. Neurology  
2005;65:1930-5. 
[12] Wilmshurst JM, Lillis S, Zhou H, et al. RYR1 mutations are a common cause 
of congenital myopathies with central nuclei. Ann Neurol  2010;68:717-26. 
[13] Clarke NF, Waddell LB, Cooper ST, et al. Recessive mutations in RYR1 are a 
common cause of congenital fiber type disproportion. Hum Mutat  
2010;31:E1544-50. 
[14] Jungbluth H, Voermans NC. Congenital myopathies: not only a paediatric 
topic. Curr Opin Neurol  2016;29:642-50. 
[15] Snoeck M, van Engelen BG, Kusters B, et al. RYR1-related myopathies: a 
wide spectrum of phenotypes throughout life. Eur J Neurol  2015;22:1094-
1112. 
[16] Loseth S, Voermans NC, Torbergsen T, et al. A novel late-onset axial 
myopathy associated with mutations in the skeletal muscle ryanodine receptor 
(RYR1) gene. J Neurol  2013;260:1504-10. 
[17] Jungbluth H, Lillis S, Zhou H, et al. Late-onset axial myopathy with cores due 
to a novel heterozygous dominant mutation in the skeletal muscle ryanodine 
receptor (RYR1) gene. Neuromuscul Disord  2009;19:344-7. 
[18] Dlamini N, Voermans NC, Lillis S, et al. Mutations in RYR1 are a common 
cause of exertional myalgia and rhabdomyolysis. Neuromuscul Disord  
2013;23:540-8. 
Page 12 of 22
13 
 
[19] Lazier J, Mah JK, Nikolic A, et al. Bilateral congenital lumbar hernias in a 
patient with central core disease--A case report. Neuromuscul Disord  
2016;26:56-9. 
[20] Casey J, Flood K, Ennis S, Doyle E, Farrell M, Lynch SA. Intra-familial 
variability associated with recessive RYR1 mutation diagnosed prenatally by 
exome sequencing. Prenat Diagn  2016;36:1020-1026. 
[21] Lopez RJ, Byrne S, Vukcevic M, et al. An RYR1 mutation associated with 
malignant hyperthermia is also associated with bleeding abnormalities. Sci 
Signal  2016;9:ra68. 
[22] Colombo I, Scoto M, Manzur AY, et al. Congenital myopathies: Natural history 
of a large pediatric cohort. Neurology  2015;84:28-35. 
[23] Manning BM, Quane KA, Ording H, et al. Identification of novel mutations in 
the ryanodine-receptor gene (RYR1) in malignant hyperthermia: genotype-
phenotype correlation. Am J Hum Genet  1998;62:599-609. 
[24] Brandom BW, Bina S, Wong CA, et al. Ryanodine receptor type 1 gene 
variants in the malignant hyperthermia-susceptible population of the United 
States. Anesth Analg  2013;116:1078-86. 
[25] Galli L, Orrico A, Cozzolino S, Pietrini V, Tegazzin V, Sorrentino V. Mutations 
in the RYR1 gene in Italian patients at risk for malignant hyperthermia: 
evidence for a cluster of novel mutations in the C-terminal region. Cell Calcium  
2002;32:143-51. 
[26] Kraeva N, Heytens L, Jungbluth H, et al. Compound RYR1 heterozygosity 
resulting in a complex phenotype of malignant hyperthermia susceptibility and 
a core myopathy. Neuromuscul Disord  2015;25:567-76. 
Page 13 of 22
14 
 
[27] Jungbluth H, Muller CR, Halliger-Keller B, et al. Autosomal recessive 
inheritance of RYR1 mutations in a congenital myopathy with cores. Neurology  
2002;59:284-7. 
[28] Dowling JJ, Lillis S, Amburgey K, et al. King-Denborough syndrome with and 
without mutations in the skeletal muscle ryanodine receptor (RYR1) gene. 
Neuromuscul Disord  2011;21:420-7. 
[29] Stoll BJ, Hansen NI, Bell EF, et al. Neonatal outcomes of extremely preterm 
infants from the NICHD Neonatal Research Network. Pediatrics  
2010;126:443-56. 
[30] Heyman R, Heckly A, Magagi J, Pladys P, Hamlat A. Intracranial epidural 
hematoma in newborn infants: clinical study of 15 cases. Neurosurgery  
2005;57:924-9. 
[31] Cullen WG. Malignant hyperpyrexia during general anaesthesia: a report of 
two cases. Can Anaesth Soc J  1966;13:437-43. 
[32] Daniels JC, Polayes IM, Villar R, Hehre FW. Malignant hyperthermia with 
disseminated intrascular coagulation during general anesthesia: a case report. 
Anesth Analg  1969;48:877-83. 
[33] Stephen CR. Fulminant hyperthermia during anesthesia and surgery. Jama  
1967;202:178-82. 
[34] Majidi S, Grigoryan M, Tekle WG, Qureshi AI. Intra-arterial dantrolene for 
refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage. 
Neurocrit Care  2012;17:245-9. 
[35] Xu SY, Hu FY, Ren LJ, et al. Dantrolene enhances the protective effect of 
hypothermia on cerebral cortex neurons. Neural Regen Res  2015;10:1279-
85. 
  
Page 14 of 22
15 
 
Figure 1.  Clinical features of the patient at birth and at 6 months of age. Initially 
contractures of upper and lower limbs were present (insert) while facial dysmorphic 
features consisted of high forehead, narrow palpebral fissure, deep-set eyes, long 
philtrum, small mouth and retrognathia. 
 
Figure 2.  MRI of the brain (A) and the spinal canal (B) at the age of two months.  
(A) Axial Susceptibility Weighted Imaging (SWI) at the level of the lateral ventricles 
detects blood deposits in the left caudothalamic groove (white arrow), on both sides 
of the choroid plexus (asterisk), along the inner surface of the left posterior horn as 
well as in the left Sylvian fissure (arrowheads). In addition, blood breakdown products 
can be seen in the dorsal portion of the longitudinal cerebral fissure (black arrow). 
(B) Sagittal T2-weighted image demonstrates a space-occupying lesion with 
heterogeneous signal abnormality in the dorsal part of the thoracic spinal canal, 
indicating a chronic epidural hemorrhage (arrows). Note partial compression and 
anterior displacement of the spinal cord (asterisk). 
 
Figure 3. Skeletal muscle pathology in the reported RYR1 patient. Skeletal muscle 
sections from the patient were stained by HE (A), NADH (B) and COX/SDH (C). Note 
the rounding of muscle fibers with marked variation in fiber size and increased 
connective tissue (A). NADH and COX/SDH stainings depict numerous eccentric 
cores (B/C). Scale bar = 100 µm. 
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